After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Trevi Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Trevi Therapeutics Inc is $667.10M. A total of 1.83 million shares were traded on the day, compared to an average of 2.28M shares.
In the most recent transaction, SCIASCIA THOMAS sold 2,631 shares of TRVI for 6.60 per share on Mar 25 ’25. After the transaction, the Chief Scientific Officer now owns 221,373 company shares. In a previous transaction on Mar 21 ’25, GOOD JENNIFER L sold 5,263 shares at 6.58 per share. TRVI shares that President & CEO owns now total 213,313.
Among the insiders who bought shares, GOOD JENNIFER L acquired of 5,263 shares on Mar 21 ’25 at a per-share price of $6.58. In another insider transaction, Simon Farrell sold 81,313 shares at $6.75 per share on Mar 10 ’25. Company shares held by the Chief Commercial Officer now total 76,900.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TRVI has a high of $7.39 and a low of $2.30.
As of this writing, TRVI has an earnings estimate of -$0.12 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.1 per share and a lower estimate of -$0.15.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TRVI’s latest balance sheet shows that the firm has $36.83M in Cash & Short Term Investments as of fiscal 2021. There were $14.63M in debt and $12.72M in liabilities at the time. Its Book Value Per Share was $1.06, while its Total Shareholder’s Equity was $17.07M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TRVI is Buy with a score of 4.88.
